Obimal (Otilonium Bromide)

Otilonium bromide acts as a calcium‑channel blocker and has antimuscarinic activity. By inhibiting calcium entry into smooth‑muscle cells and blocking muscarinic receptors, it lowers the contractile activity of gastrointestinal muscles, thereby relieving spasms and related pain.

The specific dosage of Obimal is determined by the prescribing clinician based on the patient’s condition, severity of symptoms, and overall health status. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety data for otilonium bromide in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against possible risks before prescribing Obimal to pregnant or nursing individuals.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Obimal’s active ingredient, otilonium bromide, combines calcium‑channel blockade with antimuscarinic effects, offering a dual mechanism that may provide more consistent relief of gastrointestinal spasms compared with agents that act solely on one pathway, such as hyoscine or dicyclomine.

Obimal should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Obimal is taken orally, usually with a glass of water. The exact timing relative to meals and frequency should follow the prescribing clinician’s directions, which are tailored to the individual’s therapeutic needs.

Serious adverse reactions, though rare, can include allergic responses such as rash or anaphylaxis, severe hypotension, cardiac arrhythmias, hepatic dysfunction, and pancreatitis. Patients should seek immediate medical attention if they experience any of these symptoms.

Obimal should be avoided in individuals with known hypersensitivity to otilonium bromide or any excipients, and caution is advised for patients with severe hepatic or renal impairment, uncontrolled cardiovascular disease, or those taking medications that may cause dangerous additive anticholinergic effects.